Top Ovarian Cancer Therapeutics companies

The 5 key players our Ovarian Cancer Therapeutics report profiles, and other companies free public records show in this market.

Key players in Ovarian Cancer Therapeutics

In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.

Also active in Ovarian Cancer Therapeutics

Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.

Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.

Top trial sponsors in Ovarian Cancer Therapeutics

Companies leading the most active studies found with this market's trial search, worldwide (key players included).

  1. AstraZeneca 25 active trials on ClinicalTrials.gov (opens in a new tab)
  2. AbbVie Inc. 16 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Eli Lilly and Company 9 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Merck & Co., Inc. 7 active trials on ClinicalTrials.gov (opens in a new tab)
  5. Daiichi Sankyo Company 6 active trials on ClinicalTrials.gov (opens in a new tab)
  6. Genmab 6 active trials on ClinicalTrials.gov (opens in a new tab)
  7. GSK PLC 6 active trials on ClinicalTrials.gov (opens in a new tab)
  8. Beijing Biotech 4 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Ovarian Cancer Therapeutics reports by place

One report for each place. Each tile opens that place's report.

Regions 7

Countries 26

Compare all 33 places for Ovarian Cancer Therapeutics, with active trials

Get the full Ovarian Cancer Therapeutics report

Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.

Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.